Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2020
Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting
Elizabeth C S Swart, Natasha Parekh, Jessica Daw, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Trends in add-on medications following metformin monotherapy for type 2 diabetes
Elizabeth Cs Swart, Lynn M Neilson, Kiraat D Munshi, et al.
Headache
|
September 30, 2020
Identifying Outcome Measures for Migraine Value-Based Contracting Using the Delphi Method
Elizabeth C S Swart, Chester B Good, Rochelle Henderson, et al.
Molecular Cancer
|
June 14, 2013
Global profiling of prolactin-modulated transcripts in breast cancer in vivo
Takahiro Sato, Thai H Tran, Amy R Peck, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 25, 2019
Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method
Elizabeth C S Swart, Lynn M Neilson, Chester B Good, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2019
Identifying Outcome Measures for Type 2 Diabetes Value-Based Contracting Using the Delphi Method
Lynn M Neilson, Elizabeth C S Swart, Chester B Good, et al.
Cardiology and Therapy
|
March 3, 2019
Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method
Lynn M Neilson, Elizabeth C S Swart, Chester B Good, et al.
Research in Social & Administrative Pharmacy : RSAP
|
November 12, 2021
Identifying outcome measures for atrial fibrillation value-based contracting using the Delphi method
Elizabeth C S Swart, Chester B Good, Rochelle Henderson, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 7, 2007
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways
Lynn M Neilson, Jianquong Zhu, Jianwu Xie, et al.
Hemasphere
|
October 7, 2022
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
Aaron T Gerds, Prithviraj Bose, Gabriela S Hobbs, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2020
Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting
Elizabeth C S Swart, Natasha Parekh, Jessica Daw, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Trends in add-on medications following metformin monotherapy for type 2 diabetes
Elizabeth Cs Swart, Lynn M Neilson, Kiraat D Munshi, et al.
Headache
|
September 30, 2020
Identifying Outcome Measures for Migraine Value-Based Contracting Using the Delphi Method
Elizabeth C S Swart, Chester B Good, Rochelle Henderson, et al.
Molecular Cancer
|
June 14, 2013
Global profiling of prolactin-modulated transcripts in breast cancer in vivo
Takahiro Sato, Thai H Tran, Amy R Peck, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 25, 2019
Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method
Elizabeth C S Swart, Lynn M Neilson, Chester B Good, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2019
Identifying Outcome Measures for Type 2 Diabetes Value-Based Contracting Using the Delphi Method
Lynn M Neilson, Elizabeth C S Swart, Chester B Good, et al.
Cardiology and Therapy
|
March 3, 2019
Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method
Lynn M Neilson, Elizabeth C S Swart, Chester B Good, et al.
Research in Social & Administrative Pharmacy : RSAP
|
November 12, 2021
Identifying outcome measures for atrial fibrillation value-based contracting using the Delphi method
Elizabeth C S Swart, Chester B Good, Rochelle Henderson, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 7, 2007
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways
Lynn M Neilson, Jianquong Zhu, Jianwu Xie, et al.
Hemasphere
|
October 7, 2022
Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications
Aaron T Gerds, Prithviraj Bose, Gabriela S Hobbs, et al.
Page
of 2